The relationship of body weight to response to endocrine therapy, steroid hormone receptors and survival of patients with advanced cancer of the breast
1988

Body Weight and Breast Cancer Treatment Response

Sample size: 227 publication Evidence: moderate

Author Information

Author(s): G. Williams, A. Howell, M. Jones

Primary Institution: Christie Hospital and Holt Radium Institute

Hypothesis

Higher body weight may lead to a lower response rate and reduced survival in women undergoing endocrine therapy for breast cancer.

Conclusion

The study found no significant relationship between body weight and survival or response to endocrine therapy in women with advanced breast cancer.

Supporting Evidence

  • High body weight was correlated with advanced tumor stage.
  • There was no significant relationship between body weight and the presence of estrogen receptors.
  • Patients above and below the median weight showed no significant differences in survival or response to therapy.

Takeaway

This study looked at how body weight affects breast cancer treatment. It found that being heavier doesn't change how well the treatment works or how long patients live.

Methodology

The study analyzed 227 women with advanced breast cancer, examining their body weight, treatment response, and survival rates.

Limitations

The study's sample size may limit the ability to detect small effects of body weight on treatment response.

Participant Demographics

The participants were 227 women with advanced breast cancer, with 59% presenting with operable disease and 41% with locally advanced tumors.

Statistical Information

P-Value

P=0.002 for tumor stage correlation, P=0.01 for PR positivity correlation, P=0.95 for survival comparison.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication